gemfibrozil 300 mg

mavacamten. candesartan 8 mg gemfibrozil will increase the level or effect of mavacamten by affecting hepatic enzyme CYP2C19 metabolism. mg 5 gt Contraindicated Strong or moderate CYP2C19 inhibitors may increase mavacamten systemic exposure, resulting in heart failure due to systolic dysfunction ombitasvir/paritaprevir/ritonavir dasabuvir (DSC) gemfibrozil will